Learn how U.S. reimbursement mechanics—coding, coverage, and payment—should shape MedTech product design, trials, and launch strategies.
Why U.S. reimbursement strategy should begin long before FDA approval if you want to survive.
Not every MedTech device gets written into policy. Here’s how to engage U.S. payers even when your innovation falls outside the playbook.